Altman Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,002
| Closed | -$1.29M | – | 100 |
|
|
2025
Q1 | $1.29M | Buy |
3,002
+144
| +5% | +$61.8K | 0.59% | 80 |
|
|
2024
Q4 | $1.49M | Buy |
2,858
+67
| +2% | +$34.9K | 0.63% | 73 |
|
|
2024
Q3 | $1.73M | Buy |
+2,791
| New | +$1.73M | 0.77% | 65 |
|
|
2024
Q2 | – | Sell |
-2,735
| Closed | -$1.58M | – | 94 |
|
|
2024
Q1 | $1.58M | Buy |
2,735
+339
| +14% | +$196K | 0.77% | 61 |
|
|
2023
Q4 | $1.27M | Sell |
2,396
-220
| -8% | -$117K | 0.67% | 71 |
|
|
2023
Q3 | $1.32M | Buy |
+2,616
| New | +$1.32M | 0.83% | 56 |
|
|
2023
Q1 | $1.12M | Buy |
2,436
+22
| +0.9% | +$10.1K | 1.03% | 46 |
|
|
2022
Q4 | $1.41M | Sell |
2,414
-26
| -1% | -$15.1K | 0.87% | 41 |
|
|
2022
Q3 | $1.24M | Sell |
2,440
-945
| -28% | -$479K | 0.78% | 43 |
|
|
2022
Q2 | $1.98M | Sell |
3,385
-2,143
| -39% | -$1.26M | 1.13% | 23 |
|
|
2022
Q1 | $3.27M | Sell |
5,528
-61
| -1% | -$36K | 1.69% | 17 |
|
|
2021
Q4 | $3.24M | Sell |
5,589
-274
| -5% | -$159K | 1.98% | 13 |
|
|
2021
Q3 | $3.71M | Sell |
5,863
-439
| -7% | -$278K | 2.05% | 8 |
|
|
2021
Q2 | $3.41M | Buy |
6,302
+211
| +3% | +$114K | 1.93% | 10 |
|
|
2021
Q1 | $2.78M | Sell |
6,091
-199
| -3% | -$90.8K | 1.79% | 11 |
|
|
2020
Q4 | $2.93M | Sell |
6,290
-27
| -0.4% | -$12.6K | 1.84% | 11 |
|
|
2020
Q3 | $2.79M | Buy |
6,317
+26
| +0.4% | +$11.5K | 1.98% | 12 |
|
|
2020
Q2 | $2.28M | Buy |
6,291
+186
| +3% | +$67.4K | 1.94% | 21 |
|
|
2020
Q1 | $1.73M | Buy |
+6,105
| New | +$1.73M | 1.61% | 30 |
|